Сторожакова Анна Эдуардовна
91 works · 67 citations · h-index 4
Top works
- EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER
- EFFICACY OF ERIBULIN IN ELDERLY PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC) IN REAL CLINICAL PRACTICE IN RUSSIAN FEDERATION
- HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE
- The prospects for applications of cardiometric approach in evaluation of cardiotoxicity under Anthracyclines therapy in patients with breast cancer
- Additional metabolic effects at the neoadjuvant chemotherapy (NCT) of locally advanced breast cancer (LABC).
- Blood levels of growth and progression factors in patients with locally advanced breast cancer during neoadjuvant chemotherapy
- Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy
- Bevacizumab in maintenance therapy for ovarian cancer patients
- Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
- Dynamics of changes in expression of VEGF neoangiogenic factor in tumor tissue bioptates in patients with squamous cell carcinoma of oral mucosa receiving cetuximab treatment and chemotherapy
- Some aspects of nivolumab administration in treatment for metastatic melanoma (clinical cases)
- Results of treatment of patients with locally advanced and metastatic non-squamous cell non-small-cell lung carcinoma with pemetrexed (by own experience)
- MORPHOFUNCTIONAL CHARACTERISTICS OF HEMATOPOIETIC TISSUE IN LYMPHOMA PATIENTS
- The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma
- Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II study
- Vinflunine as second-line therapy for advanced urothelial carcinoma: Russian observational study
- A study of prevalence of polymorphic variants of genes of blood coagulation factors in onco-logical patients
- Modern aspects of immunotherapy with checkpoint inhibitors in melanoma
- RESPONSE TO CHEMOTHERAPY IN BREAST CANCER PATIENTS MAY DEPEND NOT ONLY ON TUMOR BIOLOGICAL SUBTYPE, BUT ALSO ON PATIENT’S HORMONAL STATUS
- Nab-paсlitaxel (Nab-P) in patients with metastatic breast cancer (mBC) with visceral crisis (VC): Efficacy and tolerability.